Indeed, this is very well exemplified in chronic granulomatous disease, which results from a failure of the phagocytic NADPH oxidase enzyme system to produce superoxide and kill invading infections leading to a predisposition to recurrent bacterial and fungal infections and the development of inflammatory granulomas (1, 2). The gene discussed is FMO5; the disease is chronic granulomatous disease.